• Downloads
  • Contact Us
  • Directions
  • Deutsch Deutsch German de
  • English English English en
  • 简体中文 简体中文 Chinese (Simplified) zh-hans
Epitype GmbH
  • Products
  • About us
    • Management
    • Team
    • Research projects
    • Publications
    • Press
    • Jobs
  • Contact
    • Directions
    • Contact Us
  • News / Blog
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

Ovarian cancer: The silent danger

Blog
EierstockkrebsShutterstock

Every year, about 7,300 women in Germany are diagnosed with ovarian cancer (ovarian carcinoma), and more than 5,000 die of the consequences. This means that one in 72 women will be diagnosed with ovarian cancer at some point in their lives. In those affected, cells on one or both ovaries change malignantly and begin to grow uncontrollably. Since there is a lot of space around the ovaries where the cancer that develops in this way can spread, many women only notice the disease late. With nasty consequences.

Who is affected?

The risk of an ovarian tumour increases with age. Ovarian cancer occurs more frequently after the age of 50. On average, those affected are 69 years old when they are diagnosed. In addition to higher age, obesity is also an ovarian cancer risk factor.

In addition, the disease can be hereditary and occur more frequently in a family (so-called familial ovarian cancer). Special attention is therefore required if there are known histories of ovarian or breast cancer in the direct family.

Other causes for ovarian cancer may include hormone replacement therapy during the menopause. Women who undergo such treatment are more likely to develop ovarian cancer. However, the risk decreases again if the hormones were taken at least ten years ago.

Women who have had children are also less likely to get ovarian cancer. This also applies to those who took the contraceptive pill or breastfed at least one child during their childbearing years.

Symptoms of Ovarian cancer is often noticed late

Because of their location in the abdominal cavity, ovarian tumours have plenty of room to grow unnoticed. This is why those affected usually have no complaints for a long time.

Suspicious circumstances can be

  • Bleeding outside the menstrual cycle or after the menopause.
  • A larger abdominal girth without gaining weight
  • Bloating, flatulence or abdominal pain, as well as unusual digestive problems that are accompanied by a worsened general condition.
  • Urinating more frequently than normal

If you have any of these symptoms and they persist over a long period of time, you should seek medical advice.

Suspected ovarian cancer: examination and treatment

If a tumour is suspected on the ovaries, they are palpated in a gynaecological examination. In addition, an ultrasound examination through the vagina is often offered. The hit rate here is critical, as tumours cannot be distinguished from other cysts in the ultrasound. If a tumour is nevertheless discovered in the ovaries, its stage determines the further treatment.

According to the FIGO classification (International Federation of Gynecology and Obstetrics), ovarian cancer is divided into four stages:

  • I: The tumour affects one or both ovaries.
  • II: The cancer spreads into the pelvic cavity.
  • III: Outside the pelvis, cancer cells are found in the abdominal cavity or lymph nodes.
  • IV: Tumour cells have spread to other parts of the body outside the abdominal cavity.

Because of the unclear symptoms of ovarian cancer, the disease is often not recognised until stage III or IV. If possible, the treating doctors remove the ovarian carcinoma completely in an operation. This is almost always followed by chemotherapy.

Ovarian cancer diagnosis: good chances of cure if detected at early stage

If diagnosed at an early stage, the chances of cure in the ovarian cancer treatment are relatively good. The relative survival rates after five years are 89 percent in stage I and 77 percent in stage II. The more advanced the tumour, the worse the chances of cure. If the tumour recurs despite surgery and chemotherapy, the disease can no longer be cured, but only treated palliatively.

Good post-treatment care is therefore very important. The actual treatment is followed by close monitoring with regular examinations. Psycho-oncological care or rehabilitation measures can also be useful.

Research project on early detection

At present, there is no special screening test for the early detection of ovarian cancer. In a cooperation with the gynaecological clinic of the University Hospital in Jena, we are researching to find suitable tumour markers for ovarian cancer for improved diagnostics. The aim is to detect the disease earlier and thus increase the chances of cure.

Ask a doctor you trust.

The contents presented here are intended solely for neutral information and general further education. It does not constitute a recommendation or advertisement of the diagnostic methods, treatments or medicines described or mentioned. The text does not claim to be complete, nor can the topicality, accuracy and balance of the information presented be guaranteed. The text is not intended to be a substitute for professional medical advice and should not be used as a basis for independent diagnosis and initiation, modification or cessation of treatment of any disease. If you have any health questions or complaints, always consult a doctor you trust!

 

Literature sources

National Health Service Great Britain (2020): Cancer of the ovaries. www.nhs.uk/conditions/ovarian-cancer

American Cancer Society: Ovarian cancer survival statistics. www.cancerresearchuk.org/cancer-statistics

Center for Disease Control: Ovarian Cancer Statistics. www.cdc.gov/cancer/ovarian/statistics

Zentrum für Krebsregisterdaten (2017): Eierstockkrebs (Ovarialkarzinom). www.krebsdaten.de/Eierstockkrebs

Universitätsklinikum Tübingen: Eierstockkrebs – der stille Feind. www.medizin.uni-tuebingen.de/expertentipps/krebsvorsorge/eierstockkrebs

Deutsches Krebsforschungszentrum (2020): Eierstockkrebs (Ovarialkarzinom). www.krebsinformationsdienst.de

Deutsche Krebsgesellschaft (2018): Eierstockkrebs: Basis-Infos für Patienten und Angehörige. www.krebsgesellschaft.de

27. October 2021/by TowerPR
Share this entry
  • Share on WhatsApp
https://www.epitype.de/wp-content/uploads/2021/10/210318_Eierstockkrebs_Shutterstock_720850753.jpg 321 845 TowerPR https://www.epitype.de/wp-content/uploads/2025/09/epitype_website-logo-300x130.png TowerPR2021-10-27 08:00:392021-10-29 16:56:45Ovarian cancer: The silent danger

Archive

Recent Posts

  • Worldwide unique test for cervical cancer as a gamechanger for the healthcare system
  • Jena Biotechnology Company Files for Insolvency
  • Bachelor thesis in biotechnology companies: From research to diagnostics 

Epitype GmbH

The Epitype GmbH, a spin-off of the University Hospital Jena, is a company working on molecular diagnostics with main focus on the development of in-vitro diagnostics based on epigenetic biomarkers.

Epitype GmbH is working according to ISO 13485 standards in research, development, production and management.

Recent Posts

  • Worldwide unique test for cervical cancer as a gamechanger for the healthcare system
  • Jena Biotechnology Company Files for Insolvency
  • Bachelor thesis in biotechnology companies: From research to diagnostics 

Contact

Epitype GmbH
Löbstedter Str. 41
07749 Jena
Germany

Phone: +49 (0)3641 5548500

Email: contact[at]epitype.de
Internet: www.epitype.de

© 2015 - 2025 Epitype GmbH Jena Germany
  • Start
  • Imprint
  • Contact Us
  • Privacy policy
Scroll to top

Cookies help us deliver our services. By using our services, you agree to our use of cookies.

Learn moreI accept

Cookie and Privacy Settings



How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.

Other external services

We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Google reCaptcha Settings:

Vimeo and Youtube video embeds:

Privacy Policy

You can read about our cookies and privacy settings in detail on our Privacy Policy Page.

Privacy policy
Einstellungen akzeptierenVerberge nur die Benachrichtigung
Epitype GmbH
Einwilligung verwalten

Um Ihnen ein optimales Erlebnis zu bieten, verwenden wir Technologien wie Cookies, um Geräteinformationen zu speichern und/oder darauf zuzugreifen. Wenn Sie diesen Technologien zustimmen, können wir Daten wie das Surfverhalten oder eindeutige IDs auf dieser Website verarbeiten. Wenn Sie Ihre Einwilligung nicht erteilen oder zurückziehen, können bestimmte Merkmale und Funktionen beeinträchtigt werden.

Funktional Always active
Die technische Speicherung oder der Zugang ist unbedingt erforderlich für den rechtmäßigen Zweck, die Nutzung eines bestimmten Dienstes zu ermöglichen, der vom Teilnehmer oder Nutzer ausdrücklich gewünscht wird, oder für den alleinigen Zweck, die Übertragung einer Nachricht über ein elektronisches Kommunikationsnetz durchzuführen.
Präferenzen
Die technische Speicherung oder der Zugriff ist für den rechtmäßigen Zweck der Speicherung von Präferenzen erforderlich, die nicht vom Abonnenten oder Benutzer angefordert wurden.
Statistiken
Die technische Speicherung oder der Zugriff, der ausschließlich zu statistischen Zwecken erfolgt. Die technische Speicherung oder der Zugriff, der ausschließlich zu anonymen statistischen Zwecken verwendet wird. Ohne eine Vorladung, die freiwillige Zustimmung deines Internetdienstanbieters oder zusätzliche Aufzeichnungen von Dritten können die zu diesem Zweck gespeicherten oder abgerufenen Informationen allein in der Regel nicht dazu verwendet werden, dich zu identifizieren.
Marketing
Die technische Speicherung oder der Zugriff ist erforderlich, um Nutzerprofile zu erstellen, um Werbung zu versenden oder um den Nutzer auf einer Website oder über mehrere Websites hinweg zu ähnlichen Marketingzwecken zu verfolgen.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
Einstellungen ansehen
  • {title}
  • {title}
  • {title}